Regular ArticleMonitoring Cancer Antigen 125 Levels in Induction Chemotherapy for Epithelial Ovarian Carcinoma and Predicting Outcome of Second-Look Procedure
References (0)
Cited by (27)
Accuracy of 18F-FDG PET/CT in detection and restaging of recurrent ovarian cancer
2017, Egyptian Journal of Radiology and Nuclear MedicineCitation Excerpt :Sequential assessment of CA 125 is used to evaluate the ovarian cancer response for treatment. Yet, normal levels of CA 125 cannot excluded the disease, and raised CA 125 levels could not differentiate localized from diffuse tumor recurrence [4–6]. Thus, imaging essentially play a major role to detect ovarian cancer recurrence [7–10].
CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma. A systematic review and meta-analysis
2009, European Journal of RadiologyCitation Excerpt :f) Data included less than 10 patients (n = 3). A total of 34 studies [21–54] (28 in English and 6 in Chinese) with 1895 subjects fulfilled all of the inclusion criteria and were considered for the analysis (Table 1). Blinding was surely in 13 studies, but the remaining 21 studies were either not blinded or their blinding status was not defined; patient recruitment was consecutive in 8 studies and not defined in 26.
Clinical advantage of calculation of CA 125 slopes variation for epithelial ovarian cancer biological monitoring
1999, Immuno-Analyse et Biologie SpecialiseeSecond-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival
1997, Gynecologic Oncology